<- Go Home
Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Market Cap
$16.9B
Volume
366.9K
Cash and Equivalents
$502.7M
EBITDA
$611.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.0B
Profit Margin
72.35%
52 Week High
$677.90
52 Week Low
$373.00
Dividend
N/A
Price / Book Value
38.97
Price / Earnings
35.52
Price / Tangible Book Value
-64.62
Enterprise Value
$16.6B
Enterprise Value / EBITDA
25.24
Operating Income
$583.4M
Return on Equity
162.15%
Return on Assets
20.10
Cash and Short Term Investments
$502.7M
Debt
$144.1M
Equity
$433.9M
Revenue
$2.8B
Unlevered FCF
$510.4M
Sector
Life Sciences Tools and Services
Category
N/A